Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

(2021) Gonzague de Pinieux et al.   PLoS One

Incidence and survival of rare cancers in the US and Europe

(2020) Laura Botta et al.   Cancer Medicine

Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia

(2020) Tomohiro Matsuda et al.   Cancer Epidemiology

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

(2020) Mrinal Gounder et al.   LANCET ONCOLOGY

When does a new sarcoma exist?

(2020) Paolo G. Casali et al.   Clinical Sarcoma Research

Incidence of rare cancers in the city of São Paulo, Brazil

(2019) Maria Teresa Bustamante-Teixeira et al.   TUMORI

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

(2019) William D Tap et al.   LANCET

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

(2018) Margaret von Mehren et al.   Journal of the National Comprehensive Cancer Network

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group

(2018) Lionel Perrier et al.   PLoS One

OUP accepted manuscript

(2018)   ANNALS OF ONCOLOGY

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2018) P G Casali et al.   ANNALS OF ONCOLOGY

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

(2017) Gemma Gatta et al.   LANCET ONCOLOGY

Rare cancers are not so rare: The rare cancer burden in Europe

(2011) Gemma Gatta et al.   EUROPEAN JOURNAL OF CANCER